Skip to content
10-Q

Quarterly Report

PRINCIPIA BIOPHARMA INC.

0001564590-19-040415

← back to feed
Filed
Nov 5, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Oct 31, 2019 32.79M sh
Shares Diluted Q3 2019 · Sep 30, 2019 24.02M sh
Shares Diluted Q3 2019 · Sep 30, 2019 23.94M sh
Shares Diluted Q3 2019 · Sep 30, 2018 6.14M sh
Shares Diluted Q3 2019 · Sep 30, 2018 3.1M sh
Capex Q3 2019 · Sep 30, 2019 $2.15M
Capex Q3 2019 · Sep 30, 2018 $455K
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$20.87M
Operating Cash Flow restated Q3 2019 · Sep 30, 2018 −$15.4M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $29.41M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $34.49M
Cash And Equivalents Q3 2019 · Sep 30, 2018 $149.05M
Cash And Equivalents Q3 2019 · Dec 31, 2017 $41.05M
Stockholders Equity Q3 2019 · Sep 30, 2019 $152.68M
Stockholders Equity Q3 2019 · Jun 30, 2019 $170.68M
Stockholders Equity Q3 2019 · Mar 31, 2019 $158.99M
Stockholders Equity Q3 2019 · Dec 31, 2018 $169.86M
Stockholders Equity Q3 2019 · Sep 30, 2018 $159.09M
Stockholders Equity Q3 2019 · Jun 30, 2018 −$140.31M
Stockholders Equity Q3 2019 · Mar 31, 2018 −$142.66M
Stockholders Equity Q3 2019 · Dec 31, 2017 −$143.46M
Current Liabilities Q3 2019 · Sep 30, 2019 $13.5M
Current Liabilities Q3 2019 · Dec 31, 2018 $16.88M
Current Assets Q3 2019 · Sep 30, 2019 $152.36M
Current Assets Q3 2019 · Dec 31, 2018 $180.77M
Total Assets Q3 2019 · Sep 30, 2019 $174.09M
Total Assets Q3 2019 · Dec 31, 2018 $195.52M
Eps Diluted Q3 2019 · Sep 30, 2019 −$0.93
Eps Diluted Q3 2019 · Sep 30, 2019 −$1.21
Eps Diluted Q3 2019 · Sep 30, 2018 $0.00
Eps Diluted Q3 2019 · Sep 30, 2018 $0.00
Eps Basic Q3 2019 · Sep 30, 2019 −$0.93
Eps Basic Q3 2019 · Sep 30, 2019 −$1.21
Eps Basic Q3 2019 · Sep 30, 2018 $0.00
Eps Basic Q3 2019 · Sep 30, 2018 $0.00
Sga Expense Q3 2019 · Sep 30, 2019 $4.97M
Sga Expense Q3 2019 · Sep 30, 2019 $14.71M
Sga Expense Q3 2019 · Sep 30, 2018 $2.89M
Sga Expense Q3 2019 · Sep 30, 2018 $7.27M
Rd Expense Q3 2019 · Sep 30, 2019 $18.37M
Rd Expense Q3 2019 · Sep 30, 2019 $52.61M
Rd Expense Q3 2019 · Sep 30, 2018 $9.2M
Rd Expense Q3 2019 · Sep 30, 2018 $26.86M
Net Income Q3 2019 · Sep 30, 2019 −$22.3M
Net Income Q3 2019 · Sep 30, 2019 −$28.87M
Net Income Q3 2019 · Jun 30, 2019 $7.12M
Net Income Q3 2019 · Mar 31, 2019 −$13.69M
Net Income Q3 2019 · Sep 30, 2018 $6.68M
Net Income Q3 2019 · Sep 30, 2018 $8.79M
Net Income Q3 2019 · Jun 30, 2018 $1.8M
Net Income Q3 2019 · Mar 31, 2018 $310K
Operating Income Q3 2019 · Sep 30, 2019 −$23.33M
Operating Income Q3 2019 · Sep 30, 2019 −$32.15M
Operating Income Q3 2019 · Sep 30, 2018 $6.48M
Operating Income Q3 2019 · Sep 30, 2018 $8.88M
Revenue Q3 2019 · Sep 30, 2019 $0
Revenue Q3 2019 · Sep 30, 2019 $35.16M
Revenue Q3 2019 · Sep 30, 2018 $18.56M
Revenue Q3 2019 · Sep 30, 2018 $43M